Immunohistologic analysis of HGAL protein expression in lymphoma subtypes
Lymphoma subtype . | Total positive* . | Percent positive . |
---|---|---|
B-cell lymphoma, N = 384 | ||
Precursor B-lymphoblastic lymphoma | 1/3 | 33 |
Follicular lymphoma | ||
Grade 1 | 23/24 | 96 |
Grade 2 | 21/21 | 100 |
Grade 3 | 59/62 | 95 |
Diffuse large B-cell lymphoma | 103/151 | 68 |
Mediastinal large B-cell lymphoma | 7/8 | 87 |
Burkitt lymphoma | 40/40 | 100 |
Extranodal marginal zone lymphoma | 0/22 | 0 |
Splenic marginal zone lymphoma | 1/8 | 12 |
Nodal marginal zone lymphoma | 1/18 | 6 |
Mantle cell lymphoma | 0/7 | 0 |
Small lymphocytic lymphoma/CLL | 0/8 | 0 |
Lymphoplasmacytic lymphoma | 0/12 | 0 |
T-cell lymphoma, N = 24 | ||
Precursor T-lymphoblastic lymphoma | 0/5 | 0 |
Peripheral T-cell lymphoma | 0/10 | 0 |
Anaplastic large cell lymphoma | 0/5 | 0 |
Nasal-type NK lymphoma | 0/4 | 0 |
Plasma cell neoplasms, N = 195 | ||
Multiple myeloma | 2/167 | 1 |
Plasma cell leukemia | 2/15 | 13 |
Plasmacytoma | 0/3 | 0 |
Monoclonal gammopathy | 0/10 | 0 |
Hodgkin lymphoma, N = 124 | ||
Lymphocyte predominant | 12/17 | 70 |
Classical Hodgkin | 78/107 | 73 |
Nodular sclerosis | 50/77 | 65 |
Mixed cellularity | 13/22 | 59 |
Lymphoma subtype . | Total positive* . | Percent positive . |
---|---|---|
B-cell lymphoma, N = 384 | ||
Precursor B-lymphoblastic lymphoma | 1/3 | 33 |
Follicular lymphoma | ||
Grade 1 | 23/24 | 96 |
Grade 2 | 21/21 | 100 |
Grade 3 | 59/62 | 95 |
Diffuse large B-cell lymphoma | 103/151 | 68 |
Mediastinal large B-cell lymphoma | 7/8 | 87 |
Burkitt lymphoma | 40/40 | 100 |
Extranodal marginal zone lymphoma | 0/22 | 0 |
Splenic marginal zone lymphoma | 1/8 | 12 |
Nodal marginal zone lymphoma | 1/18 | 6 |
Mantle cell lymphoma | 0/7 | 0 |
Small lymphocytic lymphoma/CLL | 0/8 | 0 |
Lymphoplasmacytic lymphoma | 0/12 | 0 |
T-cell lymphoma, N = 24 | ||
Precursor T-lymphoblastic lymphoma | 0/5 | 0 |
Peripheral T-cell lymphoma | 0/10 | 0 |
Anaplastic large cell lymphoma | 0/5 | 0 |
Nasal-type NK lymphoma | 0/4 | 0 |
Plasma cell neoplasms, N = 195 | ||
Multiple myeloma | 2/167 | 1 |
Plasma cell leukemia | 2/15 | 13 |
Plasmacytoma | 0/3 | 0 |
Monoclonal gammopathy | 0/10 | 0 |
Hodgkin lymphoma, N = 124 | ||
Lymphocyte predominant | 12/17 | 70 |
Classical Hodgkin | 78/107 | 73 |
Nodular sclerosis | 50/77 | 65 |
Mixed cellularity | 13/22 | 59 |
Cases were scored positive if > 30% of lymphoma cells stained for HGAL